mark cuban pharmacy glp-1 Pharm Exec Exclusive: Talks Drug Pricing Shark Tank's Mark Cuban has

In addition to providing coverage of these drugs for obesity, which would be a new indication in Medicare and in most states under Medicaid, these efforts will also allow beneficiaries in participating states and Part D plans to access GLP-1s for obesity at a lower out-of-pocket cost than if they were to purchase them with cash at the direct-to-consumer prices offered by the manufacturers

Its a way to approach weight care with confidence, knowing youre backed by a plan that fits your unique needs

The term obesity describes a condition characterised by an excessive or abnormal disposition of fat that presents a risk to health

These are the preferred choice for any protocol where medication cost is a factor, which means essentially all home GLP-1 therapy